author-photo

Grant Langdon

Pfizer

7

Papers

46

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Systemic inhibition of p38 MAPK improves lung function and inflammatory markers in moderate-severe COPD

2015 European Respiratory Journal
Show All
- Source
- Cite
- Save
Citations (0)
The pharmacokinetics of lersivirine (UK-453,061) and HIV-1 protease inhibitor coadministration in healthy subjects.

2012 Journal of Acquired Immune Deficiency Syndromes
Show All
- Source
- Cite
- Save
Citations (4)
Effects of ketoconazole and valproic acid on the pharmacokinetics of the next generation NNRTI, lersivirine (UK‐453,061), in healthy adult subjects

2012 British Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (9)
The effect of lersivirine, a next-generation NNRTI, on the pharmacokinetics of midazolam and oral contraceptives in healthy subjects

2012 European Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (7)
Safety and tolerability of lersivirine, a nonnucleoside reverse transcriptase inhibitor, during a 28-day, randomized, placebo-controlled, Phase I clinical study in healthy male volunteers.

2010 Clinical Therapeutics
Show All
- Source
- Cite
- Save
Citations (7)